Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamineautoreceptor action
Dn. Ruskin et al., Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamineautoreceptor action, BIOL PSYCHI, 49(4), 2001, pp. 340-350
Background: Current theories propose that low doses of catecholaminergic st
imulants reduce symptoms in patients with attention-deficient/hyperactivity
disorder by acting on autoreceptors to reduce catecholaminergic transmissi
on; few data are available that directly address this hypothesis.
Methods: We investigated the autoreceptor and postsynaptic receptor actions
of systematically administered stimulants on dopaminergic systems in rats
with single-unit recording in the substantia nigra pars compacta and globus
pallidus, respectively.
Results: Dose-response curves for rate indicated that the potencies of the
indirect-acting agonists methylphenidate and D-amphetamine at dopaminergic
autoreceptors were not greater than at postsynaptic receptors; in fact, D-a
mphetamine was more potent postsynaptically. In addition to effects on firi
ng rate, spectral/wavelet analyses indicated that these drugs had prominent
effects on postsynaptic multisecond oscillations. These oscillations were
shifted by stimulants from baseline periods of similar to 30 sec to periods
of 5-10 sec. Effects on pattern were found at doses as low as 1.0 mg/kg (m
ethylphanidate) and 0.2 mg/kg (D-amphetamine). At this latter dose, D-amphe
tamine had little effect presynaptically.
Conclusions: These are prior results demonstrate that there is no autorecep
tor-preferring dose range of catecholaminergic stimulants; these drugs at l
ow doses are unlikely to reduce motor activity by this mechanism. Nonethele
ss, they might affect attentive and cognitive processes by modulating multi
second temporal patterns of central activity. (C) 2001 Society of Biologica
l Psychiatry.